NESPRO 100
Composition:
Each enteric coated tablet contains: Aspirin 100mg.
Indications:
- Vascular Indications: Aspirin is indicated to:
- Reduce the combined risk of death and nonfatal stroke in patients who have had ischemic stroke or transient ischemia of the brain due to fibrin platelet emboli
- Reduce the risk of vascular mortality in patients with a suspected acute MI
- Reduce the combined risk of death and nonfatal Ml in patients with a previous MI or unstable angina pectoris. .
- Reduce the combined risk of MI and sudden death in patients with chronic stable angina pectoris.
- Revascularization Procedures: Aspirin is indicated in patients who have undergone revascularization procedure (Coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA) or carotid endarterectomy) when there is a preexisting condition for which aspirin is already indicated.
Rheumatologic disease indication: aspirin is indicated for the relief of the signs and symptoms of rheumatoid arthritis, juvenile rheumatoid arthritis, osteoarthritis, spondyloarthropathies, and arthritis and pleurisy associated with Systemic lupus erythematous.
Dosage:
Ischemic Stroke and TIA: 50-325 mg once a day, continue therapy indefinitely.
Suspected Acute Myocardial infarction (MI): The initial dose of 160-162.5 mg is administered as soon as an Ml is suspected. The maintenance dose of 160-162.5 mg a day is continued for 30 days post-infarction, after 30days consider further therapy based on dosage for prevention of recurrent MI.
Prevention of recurrent MI: 75-325 mg once a day, continue therapy indefinitely.
Unstable angina pectoris: 75-325 mg once a day, continue therapy indefinitely.
Chronic Stable Angina Pectoris: 75-325 mg once a day, continue therapy indefinitely.
Coronary artery bypass grafting (CAEG): 325 mg daily starting 6 hours post-procedure. Continue therapy for one year post-procedure.
Percutaneous trans-luminal coronary angioplasty (PTCA): The initial dose of 325 mg should be given 2 hours pre-surgery. Maintenance dose is 160-325 mg daily, continue therapy indefinitely.
Carotid Endarterectomy: Doses of 80 mg once daily to 650 mg twice daily, started pre-surgery, are recommended, continue therapy indefinitely.
Rheumatoid arthritis: The initial dose is 3 g a day in divided doses. Increase as needed for anti-inflammatory efficacy with target plasma salicylates level of 150-300 mcg/ml. at high doses (plasma levels of greater than 200 mcg/ml), the incidence of toxicity increase.
Juvenile rheumatoid arthritis: Initial dose is 90-130 mg/kg/day in divided doses, Increase as needed for anti-inflammatory efficacy with target plasma salicylates levels of 150-300 mcg/ml.
Spondyloarthropathies: Up to (4g) day in divided doses
Osteoarthritis: Up to (3g) per day in divided doses
Arthritis and pleurisy of SLE: The initial dose is (3g) a day in divided doses. Increase as needed for anti-inflammatory efficacy with target plasma salicylate level of 150-300 mcg/ml.
Package:
Carton box contains 3bilsters (PVC/Aluminum) each one contains 10 enteric coated tablets.